ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

How to Safely Re-engage Allergy Immunotherapy Patients after Coronavirus Shutdown

June 15, 2020

  • Tweet
  • Email
Print-Friendly Version

Protecting Yourself

As restrictions lift in different parts of the country, while incidence and exposure continue to be monitored, consideration of which protocols will be implemented for patient and staff safety are vital, and use of personal protective equipment (PPE) is of paramount importance. When resuming SCIT injections, providers should wear gloves, gown, mask, hair covering, and eye protection. The adequacy and specific type of PPE to be used during SCIT administration depends upon hospital and government recommendations as restrictions are lifted. 

You Might Also Like

  • Sublingual Immunotherapy a Potential Treatment for Allergic Rhinitis
  • Sublingual Immunotherapy (SLIT) Quality of Life Outcomes
  • FDA Approves First Sublingual Allergy Immunotherapy Agents
  • Clarity Needed on Which Patients with PTC Can Be Safely Observed
Explore This Issue
June 2020
* This example is based on expert opinion as there is a lack of scientific data. Treatment of individual patients will require analysis of their medical condition and individual dosing for immunotherapy.

* This example is based on expert opinion as there is a lack of scientific data. Treatment of individual patients will require analysis of their medical condition and individual dosing for immunotherapy.

COVID-19 is transmitted through the aerosolization of viral particles, a fact that’s particularly concerning in allergy management. Use of pulmonary function testing, peak flow testing (PFT), and nebulized medications can promote the aerosolization of viral particles. Whenever possible, these procedures should be deferred or replaced with alternatives—for example, inhaled corticosteroids can be delivered by metered-dose inhalers rather than nebulizer, chest auscultation can be performed rather than PFT, and PFT may even be deferred until COVID-19 restrictions are eased. Frequent surface disinfection with 70% ethanol should be part of an allergy practice’s protocol.

A practice must also consider how it will manage patients and maintain social distancing as it reopens. Limiting additional family members, reducing shared materials such as magazines, pens, or check-in kiosks, and wider seat spacing in waiting areas are some issues to consider. 

Patients and staff should be regularly monitored for COVID-19 infection symptoms. Prescreening from the time of booking until the time of entry into the office should be considered. Screening questions should ask about exposure to COIVD-19, cough, shortness of breath, fever, and anosmia. Temperature monitoring can also be implemented prior to entry into the clinic. Patients displaying COVID-19 infection signs and symptoms should be referred to primary care for appropriate testing, when possible, rather than receiving their SCIT injections. All these precautions and more must be a significant part of the decision to reopen. 


Dr. Alpen Patel is the 2019-2020 president, Dr. Michael Platt is the treasurer, and Dr. Doug Dawson is the socioeconomic chair of the AAOA.

Pages: 1 2 | Single Page

Filed Under: Features Tagged With: coronavirus, COVID19, immunotherapy, patient care, patient safetyIssue: June 2020

You Might Also Like:

  • Sublingual Immunotherapy a Potential Treatment for Allergic Rhinitis
  • Sublingual Immunotherapy (SLIT) Quality of Life Outcomes
  • FDA Approves First Sublingual Allergy Immunotherapy Agents
  • Clarity Needed on Which Patients with PTC Can Be Safely Observed

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Vertigo in the Elderly: What Does It Mean?
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Is the Training and Cost of a Fellowship Worth It? Here’s What Otolaryngologists Say
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Why Virtual Grand Rounds May Be Here to Stay
    • Otolaryngologist Leverages His Love of Pinball into Second Business
    • These New Imaging Advances May Help to Protect Parathyroids
    • Is the Training and Cost of a Fellowship Worth It? Here’s What Otolaryngologists Say
    • Which Otologic Procedures Poses the Greatest Risk of Aerosol Generation?

Polls

Have you used 3D-printed materials in your otolaryngology practice?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.